InvestorsHub Logo

cybermich

02/24/17 9:42 AM

#93081 RE: blueyedcatch #93079

a good treatment for Alzheimers IS huge..

imagine a "preventative" treatment (think example of cholesterol medication)..

where folks over the age of fifty are taking this medication to prevent the disease from taking hold..

even HUGER market.

prevention.. treatment.. cure..

huge market regardless.

Graniteguy

02/24/17 9:45 AM

#93082 RE: blueyedcatch #93079

I see the most effective use for A2-73 going forward as a prophylactic or preventative drug for Alzheimer's, particularly for those who have a family history of Alzheimer's disease or have been identified as showing signs of Dementia and or Alzheimer's. This is not to discount A2-73's ability to bring patients "back from the brink" of more advanced Alzheimer's stages, but that level of efficacy still needs more confirmation. The fact that we can see that there were six super responders speaks to that hope and I am optimistic that for certain classes of patients, that this will be confirmed in this next P3 Trial.

falconer66a

02/24/17 9:59 AM

#93085 RE: blueyedcatch #93079

No, Anavex 2-73 will not cure Alzheimer's.

That's because the root cause(s) of the disease will remain in any person treated with the drug. Stop the drug, and the disease symptoms are likely, in time, to resume.

Insulin does not cure diabetes. It controls it. Anavex 2-73 can do two things; prevent the onset (appearance) of CNS diseases, or, stop or reverse their progression.

The likelyhood of just popping a few Anavex 2-73 pills for a week or so to permanently prevent or treat any CNS disease is remote. As with insulin in diabetes, patients will have to take on-going, maintenance dosings of Anavex 2-73.

Of course, this is exactly the kind of product Big Pharmas want in their arsenals, drugs that have to be purchased continually, creating persisting revenue streams.

And this is why Dr. Missling will be extremely reluctant to sell off Anavex technologies to other companies. Keep the proprietary molecules in-house, yielding stunning, persisting financial rewards. External firms may be engaged in manufacture, packaging, distribution, and sales. But Anavex Life Science Corp. reaps the primary rewards.

Anavex Life Science Corp. I believe, is destined to be a Big Pharmaceutical. Those of us with AVXL shares will be well-rewarded — as will those who are treated with Anavex drugs.